DoD Tuberous Sclerosis Complex, Exploration-Hypothesis Development Award
ID: 353647Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353647
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), has announced the FY24 funding opportunity for the Tuberous Sclerosis Complex (TSC) Exploration-Hypothesis Development Award. This grant aims to support innovative research projects that explore high-risk, high-gain concepts related to TSC, particularly focusing on neuropsychiatric disorder treatments, tumor prevention, and the application of advanced technologies in addressing TSC. The initiative is crucial for advancing medical research that impacts both military personnel and the civilian population, with an estimated total program funding of $1.2 million allocated for up to five awards. Interested applicants must submit a Letter of Intent by June 12, 2024, followed by a full application due by August 1, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524TSCRPEHDA_GG.pdf
    The Department of Defense (DOD) has issued a funding opportunity announcement for the FY24 Tuberous Sclerosis Complex Research Program, specifically the Exploration-Hypothesis Development Award. This initiative aims to support innovative research projects that address Tuberous Sclerosis Complex (TSC) and its associated health impacts on active-duty military personnel, veterans, and the civilian population. The total funding available for this award is approximately $8 million, with expectations to allocate around $1.2 million to fund up to five applications. Applicants must submit a two-step process: a Letter of Intent by June 12, 2024, followed by a full application by August 1, 2024. The proposed research should focus on areas like neuropsychiatric disorder treatments, tumor prevention, and the utilization of advanced technologies in addressing TSC. Innovations and significant impacts on health outcomes are critical evaluation criteria. Eligible applicants include both domestic and international organizations, with a budget cap of $150,000 for the entire research period, which may last up to two years. The review process consists of a two-tiered evaluation of technical merit followed by program relevance assessment. This funding opportunity reflects the DOD's commitment to advancing medical research in areas critical to military and public health.
    Similar Opportunities
    DoD Multiple Sclerosis, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Multiple Sclerosis Clinical Trial Award to support clinical trials aimed at improving treatment and management of multiple sclerosis (MS). This funding opportunity encourages innovative trials that may include new pharmacologic agents, devices, or emerging technologies, with a total estimated program funding of $8 million and the expectation of awarding three grants. Eligible applicants include unrestricted entities, and the funding levels are set at a maximum of $2 million for small-scale trials and $4 million for larger-scale studies, with a pre-application deadline of June 10, 2024, and a full application deadline of October 7, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    CDMRP Neurofibromatosis Exploration-Hypothesis Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Neurofibromatosis Exploration-Hypothesis Development Award, aimed at funding innovative research related to neurofibromatosis (NF). This grant supports the exploration of high-risk, high-gain concepts to enhance understanding and treatment of NF1, NF2, and schwannomatosis, with an estimated total program funding of $1.12 million and the expectation to fund approximately seven projects. The application process is two-tiered, requiring pre-applications by September 12, 2024, and full applications by October 3, 2024, with a focus on innovation, research feasibility, and impact on NF research and patient care. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Traumatic Brain Injury and Psychological Health, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Traumatic Brain Injury and Psychological Health Translational Research Award (TRA) to advance research aimed at improving care for psychological health conditions and traumatic brain injuries (TBI). This grant opportunity focuses on hypothesis-driven research that seeks to develop novel healthcare products, clinical practices, and technologies, with an emphasis on translational research that leads to practical applications in clinical settings. With an estimated total program funding of $17.05 million, the program anticipates awarding approximately 14 grants, with funding caps of $500,000 for smaller projects and $1 million for larger, more complex research initiatives. Interested applicants must submit a pre-application by June 27, 2024, and full applications by October 3, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org.
    DOD Traumatic Brain Injury and Psychological Health, Emerging Topics Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Traumatic Brain Injury and Psychological Health Emerging Topics Research Award (TBIPHRP ETRA) to fund research addressing emerging topics related to traumatic brain injury (TBI) and psychological health within the military context. This grant aims to accelerate research that will lead to new clinical applications, healthcare products, and guidelines that benefit Service Members, Veterans, and their families, with a total estimated funding of $16 million for approximately nine awards. The program encourages collaborative research, particularly partnerships between early-career and experienced investigators, and supports both preclinical and clinical research, including clinical trials. Interested applicants must submit their proposals by October 3, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Tick-Borne Disease Therapeutic/Diagnostic Research Award to support innovative research aimed at addressing tick-borne diseases, particularly Lyme disease. This grant seeks applications focused on therapeutic and diagnostic development with demonstrated feasibility, emphasizing projects that can improve patient care and quality of life for military Service Members, Veterans, and the general public. With an estimated total program funding of $2,656,000 and the expectation of awarding two grants, applicants must submit a pre-application through eBRAP by October 3, 2024, followed by a full application via Grants.gov upon invitation. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Reconstructive Transplant, Idea Discovery Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Reconstructive Transplant Idea Discovery Award, a federal grant aimed at supporting innovative and high-risk research in reconstructive transplant and immunotherapy. This grant seeks to generate robust data that can lead to new scientific investigations, particularly focusing on enhancing immunosuppression techniques and advancing tissue preservation strategies relevant to military personnel and veterans. With an estimated total program funding of $2.5 million, the award will provide up to $500,000 for each selected project over a two-year period, contingent upon the availability of federal funds and the merit of applications. Interested applicants must submit a pre-application by August 7, 2024, followed by a full application due by October 23, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Traumatic Brain Injury and Psychological Health, Focused Program Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2024 (FY24) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Focused Program Award (FPA) to support multidisciplinary research aimed at addressing critical challenges related to psychological health conditions and traumatic brain injuries (TBI). The program seeks applications that propose collaborative research projects, with a strong emphasis on clinical applications, including health care products, technologies, and practice guidelines, while ensuring that each project aligns with a unifying overarching challenge relevant to military health. With an estimated total program funding of $46.5 million and the expectation of awarding approximately six grants, interested applicants must submit a pre-application by June 27, 2024, followed by a full application due by October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Multiple Sclerosis, Investigator-Initiated Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Fiscal Year 2024 Multiple Sclerosis Research Program (MSRP) via the Investigator-Initiated Research Award (IIRA). This grant aims to support innovative and high-impact research projects related to Multiple Sclerosis (MS), particularly those that can enhance patient care and quality of life, while excluding clinical trials. The program emphasizes research on central nervous system repair, disease progression correlates, symptom biology, and MS etiology, with a total funding pool of $6 million expected to yield approximately six awards, each up to $1 million over three years. Interested applicants must submit a pre-application by June 10, 2024, followed by a full application due by October 7, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Psychedelic Treatment Research Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2024 Psychedelic Treatment Research Clinical Trial Award (PTRCTA) to support clinical trials evaluating treatments for post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) among U.S. Service Members using specific psychedelic substances. Applicants are required to propose studies that address at least one of the covered conditions and utilize one or more of the eligible psychedelic substances, including MDMA, psilocybin, and ibogaine, with trials ranging from small proof-of-concept studies to larger efficacy trials. With an estimated total program funding of $9.8 million and the expectation of awarding two grants, interested parties must submit pre-applications by September 20, 2024, and full applications by October 4, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.